Application 209092

Type
NDA
Sponsor
NOVARTIS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001KISQALIRIBOCICLIB SUCCINATETABLET;ORALEQ 200MG BASEYesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0078-0860KISQALIribociclibNovartis Pharmaceuticals CorporationNDACurrent
0078-0860KISQALIribociclibNovartis Pharmaceuticals CorporationNDACurrent
0078-0860KISQALIribociclibNovartis Pharmaceuticals CorporationNDACurrent
0078-0860KISQALIribociclibNovartis Pharmaceuticals CorporationNDACurrent
0078-0860KISQALIribociclibNovartis Pharmaceuticals CorporationNDACurrent
0078-0860KISQALIribociclibNovartis Pharmaceuticals CorporationNDACurrent
0078-0860KISQALIribociclibNovartis Pharmaceuticals CorporationNDACurrent
0078-0860KISQALIribociclibNovartis Pharmaceuticals CorporationNDACurrent
0078-0860KISQALIribociclibNovartis Pharmaceuticals CorporationNDACurrent
0078-0860KISQALIribociclibNovartis Pharmaceuticals CorporationNDACurrent
0078-0860KISQALIribociclibNovartis Pharmaceuticals CorporationNDACurrent
0078-0860KISQALIribociclibNovartis Pharmaceuticals CorporationNDACurrent
0078-0860KISQALIribociclibNovartis Pharmaceuticals CorporationNDACurrent
0078-0860KISQALIribociclibNovartis Pharmaceuticals CorporationNDACurrent
0078-0867KISQALIribociclibNovartis Pharmaceuticals CorporationNDACurrent
0078-0867KISQALIribociclibNovartis Pharmaceuticals CorporationNDACurrent
0078-0867KISQALIribociclibNovartis Pharmaceuticals CorporationNDACurrent
0078-0867KISQALIribociclibNovartis Pharmaceuticals CorporationNDACurrent
0078-0867KISQALIribociclibNovartis Pharmaceuticals CorporationNDACurrent
0078-0867KISQALIribociclibNovartis Pharmaceuticals CorporationNDACurrent
0078-0867KISQALIribociclibNovartis Pharmaceuticals CorporationNDACurrent
0078-0867KISQALIribociclibNovartis Pharmaceuticals CorporationNDACurrent
0078-0867KISQALIribociclibNovartis Pharmaceuticals CorporationNDACurrent
0078-0867KISQALIribociclibNovartis Pharmaceuticals CorporationNDACurrent
0078-0867KISQALIribociclibNovartis Pharmaceuticals CorporationNDACurrent
0078-0867KISQALIribociclibNovartis Pharmaceuticals CorporationNDACurrent
0078-0867KISQALIribociclibNovartis Pharmaceuticals CorporationNDACurrent
0078-0867KISQALIribociclibNovartis Pharmaceuticals CorporationNDACurrent
0078-0874KISQALIribociclibNovartis Pharmaceuticals CorporationNDACurrent
0078-0874KISQALIribociclibNovartis Pharmaceuticals CorporationNDACurrent
0078-0874KISQALIribociclibNovartis Pharmaceuticals CorporationNDACurrent
0078-0874KISQALIribociclibNovartis Pharmaceuticals CorporationNDACurrent
0078-0874KISQALIribociclibNovartis Pharmaceuticals CorporationNDACurrent
0078-0874KISQALIribociclibNovartis Pharmaceuticals CorporationNDACurrent
0078-0874KISQALIribociclibNovartis Pharmaceuticals CorporationNDACurrent
0078-0874KISQALIribociclibNovartis Pharmaceuticals CorporationNDACurrent
0078-0874KISQALIribociclibNovartis Pharmaceuticals CorporationNDACurrent
0078-0874KISQALIribociclibNovartis Pharmaceuticals CorporationNDACurrent
0078-0874KISQALIribociclibNovartis Pharmaceuticals CorporationNDACurrent
0078-0874KISQALIribociclibNovartis Pharmaceuticals CorporationNDACurrent
0078-0874KISQALIribociclibNovartis Pharmaceuticals CorporationNDACurrent
0078-0874KISQALIribociclibNovartis Pharmaceuticals CorporationNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
84362SUPPL 2025-12-08
84344SUPPL 2025-12-01
82978SUPPL 2025-07-29
82971SUPPL 2025-07-29
81286SUPPL 2025-02-19
81225SUPPL 2025-02-12
80223SUPPL 2024-11-20
79998SUPPL 2024-10-25
79891SUPPL 2024-10-15
79885SUPPL 2024-10-15
79656SUPPL 2024-09-19
79159SUPPL 2024-07-24
79151SUPPL 2024-07-23
75307SUPPL 2023-08-29
75298SUPPL 2023-08-28
72263SUPPL2022-10-07
72237SUPPL2022-10-04
69591SUPPL2021-12-16
69529SUPPL2021-12-13
68644SUPPL2021-09-20
68631SUPPL2021-09-17
63815SUPPL2020-07-07
63813SUPPL2020-07-07
61616SUPPL2020-01-22
61612SUPPL2020-01-22
59973SUPPL2019-09-11
59968SUPPL2019-09-11
56321SUPPL2019-06-03
55355SUPPL2018-08-29
54954SUPPL2018-07-24
47732ORIG2017-03-28
47530ORIG2017-03-13
47529ORIG2017-03-13